Search Tag: PAXLOVID

Executive Health Management

Pfizer-receives-u-s-fda-emergency-use-authorization-for-novel-covid-19-oral-antiviral-treatment

2021 22 Dec

PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) is authorized for emergency use in both high-risk adults and high-risk pediatric patients 12 years of age and older weighing at least 40 kg EUA based on clinical data from EPIC-HR study, showing PAXLOVID reduced risk of hospitalization or death by 89% (within three days of symptom...Read more